Atrial Fibrillation in Aging Heart: Role of Senescent Atrial Cells
衰老心脏中的心房颤动:衰老心房细胞的作用
基本信息
- 批准号:10706970
- 负责人:
- 金额:$ 21.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAdultAffectAgeAgingAnimal ModelAnti-Arrhythmia AgentsAnti-Inflammatory AgentsArrhythmiaAtrial FibrillationBiological MarkersBiopsyCardiacCardiac Surgery proceduresCartoonsCell AgingCell physiologyCellsCharacteristicsClinical TrialsComplexDNA DamageDiseaseElectrocardiogramFibroblastsFibrosisFutureGamma-H2AXGeneticGoalsGrowth FactorHealth BenefitHeartHeart AtriumHeterogeneityHospitalizationHumanIncidenceInflammationInflammatoryInflammatory ResponseInvestigationLeft atrial structureLongevityMaintenanceMapsMediatingMetalloproteasesMolecularMolecular ProfilingMusMuscle CellsMyofibroblastOpticsOrganOryctolagus cuniculusPathogenesisPatientsPersonsPharmaceutical PreparationsPhenotypePhysiologicalPlayPopulationPrevalenceProceduresProcessPrognosisProspective StudiesResearchResearch PersonnelRight atrial structureRiskRoleSamplingSerumSinusSomatic CellStainsStretchingStrokeTelomere ShorteningTestingTissuesUnited StatesWalkingage groupagedaging populationauricular appendagebeta-Galactosidasebiological adaptation to stresscell typechemokinecostcytokinecytotoxicgenotoxicityin vivoinflammatory markerlifetime riskmortality riskmouse modelnovelnovel therapeuticspharmacologicpreventsenescencestressortranscriptome sequencing
项目摘要
The most common arrhythmia in the aging population is atrial fibrillation (AF), which carries an estimated
lifetime risk of 25% after the age of 40 years. Cellular senescence is a stress response that is characterized by
an irreversible loss of proliferative capacity, accompanied by a complex senescence-associated secretory
phenotype (SASP) that can have profound effects on neighboring cells in the tissue. Our research plan is
based on the following premises: Cellular senescence of atrial myocytes (AMs) and atrial cardiac fibroblasts
(ACMFs) plays an important role in fibrosis, inflammation and arrhythmogenesis. The overarching hypothesis
of our proposal is that atrial cell senescence is an important component of atrial aging and the increase
incidence of AF. Specifically, we postulate that in the aging human (and rabbit) atrium, the interplay between
aging and senescent AMs that have a lower threshold for arrhythmogenic activity and together with senescent
ACMFs leads to fibrosis and the triggering of AF. This R21 proposal brings together several investigators with
very different expertise to investigate mechanisms of AF in the aging heart, using a novel age-appropriate
large animal model (rabbit), and human samples obtained from explanted hearts and right atrial appendage. In
Aim 1 the Koren group will investigate the aging rabbit atria, as compared to the young atria, and correlate the
arrhythmogenesis with molecular and cellular analysis of AMs and ACMFs. Senescence will be manipulated in
vivo under Aim1 using pharmacologic approaches. Optical mapping of hearts ex vivo will be used to study
arrhythmogenesis. In Aim 2 the group will study human explanted atria as well as tissue and AMs obtained
from right atrial appendages during open heart surgery. In summary, we envision that by understanding the
aging mechanisms that control cellular senescence we will be able to reduce fibrosis and the incidence of AF.
老龄化人群中最常见的心律失常是心房颤动(AF),它带有估计的
40岁以后的终身风险为25%。细胞衰老是一种应力反应,其特征是
不可逆转的增殖能力丧失,伴随着复杂的衰老相关分泌
表型(SASP)可以对组织中的相邻细胞产生深远影响。我们的研究计划是
基于以下前提:心房心肌细胞(AMS)和心房成纤维细胞的细胞衰老
(ACMF)在纤维化,炎症和心律失常发生中起重要作用。总体假设
我们的建议是,心房细胞衰老是心房老化和增加的重要组成部分
AF的发病率。具体而言,我们假设在衰老的人(和兔)中庭中,
衰老和衰老AM具有较低的心律失常活动阈值,并且与衰老
ACMF会导致纤维化和AF的触发。该R21提案汇集了几位调查人员
使用新颖的年龄适中,以研究衰老心脏中AF的机制的非常不同的专业知识
大型动物模型(兔子)以及从外植的心脏和右心肢获得的人类样品。在
目标1与年轻的心房相比,科伦组将调查老化的兔子心房,并将其关联
心律失常,通过AM和ACMF的分子和细胞分析。衰老将被操纵
AIM1下使用药理方法的体内。心脏的光学映射将用于研究
心律失常。在AIM 2中,该小组将研究人类外养心房以及已获得的组织和AM
心脏手术期间的右心窝。总而言之,我们设想,通过了解
控制细胞衰老的老化机制,我们将能够降低纤维化和AF的发生率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GIDEON KOREN其他文献
GIDEON KOREN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GIDEON KOREN', 18)}}的其他基金
Atrial Fibrillation in Aging Heart: Role of Senescent Atrial Cells
衰老心脏中的心房颤动:衰老心房细胞的作用
- 批准号:
10345318 - 财政年份:2022
- 资助金额:
$ 21.63万 - 项目类别:
Scarring and Arrhythmia in Infarcted Aged Hearts: Role of Senescent Fibroblasts
梗死老年心脏的疤痕和心律失常:衰老成纤维细胞的作用
- 批准号:
10335140 - 财政年份:2019
- 资助金额:
$ 21.63万 - 项目类别:
Cardiac ubiquitin ligases: regulation and role in modulating cardiac excitation.
心脏泛素连接酶:调节心脏兴奋的调节和作用。
- 批准号:
9974406 - 财政年份:2017
- 资助金额:
$ 21.63万 - 项目类别:
A Multi-Scale Approach to Cardiac Arrhythmia: from the Molecule to the Organ
治疗心律失常的多尺度方法:从分子到器官
- 批准号:
8411857 - 财政年份:2013
- 资助金额:
$ 21.63万 - 项目类别:
A Multi-Scale Approach to Cardiac Arrhythmia: from the Molecule to the Organ
治疗心律失常的多尺度方法:从分子到器官
- 批准号:
8708950 - 财政年份:2013
- 资助金额:
$ 21.63万 - 项目类别:
Sex Hormones and Cardiac Arrhythmia in Transgenic LQT2 Rabbits
转基因 LQT2 兔的性激素和心律失常
- 批准号:
8055499 - 财政年份:2009
- 资助金额:
$ 21.63万 - 项目类别:
Sex Hormones and Cardiac Arrhythmia in Transgenic LQT2 Rabbits
转基因 LQT2 兔的性激素和心律失常
- 批准号:
7789586 - 财政年份:2009
- 资助金额:
$ 21.63万 - 项目类别:
Sex Hormones and Cardiac Arrhythmia in Transgenic LQT2 Rabbits
转基因 LQT2 兔的性激素和心律失常
- 批准号:
7668883 - 财政年份:2009
- 资助金额:
$ 21.63万 - 项目类别:
Sex Hormones and Cardiac Arrhythmia in Transgenic LQT2 Rabbits
转基因 LQT2 兔的性激素和心律失常
- 批准号:
8242689 - 财政年份:2009
- 资助金额:
$ 21.63万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
- 批准号:
10748776 - 财政年份:2024
- 资助金额:
$ 21.63万 - 项目类别:
In vivo feasibility of a smart needle ablation treatment for liver cancer
智能针消融治疗肝癌的体内可行性
- 批准号:
10699190 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome
什瓦赫曼-戴蒙德综合征应激反应的基因剖析
- 批准号:
10594366 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
LRP1 作为成体神经干细胞和中风后反应中 CXCR4 的新型调节剂
- 批准号:
10701231 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Elucidating signaling networks in Anterior Segment development, repair and diseases
阐明眼前节发育、修复和疾病中的信号网络
- 批准号:
10718122 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别: